iPS Cells and Neurodegenerative Disease © Sterneckert Lab

Sterneckert Lab

Induced pluripotent stem cell (iPSC) technology offers a unique opportunity to study neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Reprogramming enables the generation of iPSC lines directly generated from fibroblasts donated by a patient with an observable phenotype and known genotype. Using iPSCs, theoretically limitless numbers of specialized cells, including neurons, can be generated that carry the same genetic mutations as the donating patient.

learn more Sterneckert Lab

iPS Cells and Neurodegenerative Disease © Sterneckert Lab
Name

Dr. Jared Sterneckert

Name

Anne-Kathrin Gerber | Assistant to Group Leader